The newly emerged Middle East respiratory syndrome coronavirus (MERS-CoV) infects human bronchial epithelial Calu-3 cells. Unlike severe acute respiratory syndrome (SARS)-CoV, which exclusively infects and releases through the apical route, this virus can do so through either side of polarized Calu-3 cells. Infection results in profound apoptosis within 24 h irrespective of its production of titers that are lower than those of SARS-CoV. Together, our results provide new insights into the dissemination and pathogenesis of MERS-CoV and may indicate that the virus differs markedly from SARS-CoV. on March 13, 2015 by UNI SOUTHERN QLD http://jvi.asm.org/ Downloaded from FIG 3 MERS-CoV, but not SARS-CoV, rapidly induces apoptosis of infected Calu-3 cells. Calu-3 cells grown in chamber slides were subjected to either SARS-CoV or MERS-CoV/EMC-2012 (MOI ϭ 0.1) or remained uninfected for 24 h before we analyzed characteristic markers of apoptosis by confocal microscopy. Specifically, the morphology of the nuclei was analyzed after staining with 4=,6-diamidino-2-phenylindole (DAPI), whereas the expression of cleaved caspase 3 (CCP3) was evaluated after staining with Alexa 488-conjugated anti-CCP3 antibodies. The resulting specimens were examined using confocal microscopy at a high magnification. (A and B) Nuclei of mock-infected cells (A) or SARS-CoV-infected cells (B) possess a homogeneously round and smooth morphology without detectable CCP3 expression. (C) In contrast, we readily detected in MERS-CoV/EMC-2012-infected cells prominent nuclear margination, chromatin condensation (arrows), and typical apoptotic bodies (arrowheads) accompanied by positive staining for CCP3 (bright green) in the cytoplasm. (D) Additionally, FITC-conjugated annexin V and propidium iodide (PI) staining was used to discriminate between early apoptotic and late apoptotic/necrotic cells in MERS-CoV/EMC-2012-infected (MOI ϭ 0.1 and 3) and uninfected Calu-3 cultures at both 12 and 24 h pi. Magnification, ϫ100.
R ecently, a novel human coronavirus (CoV) causing acute pneumonia with renal failure emerged in the Middle East. Between June 2012 and 22 May 2013, infections caused by this virus, now called Middle East respiratory syndrome (MERS)-CoV (1) , resulted in 21 deaths among 43 confirmed cases worldwide (2) . Such an alarming mortality rate of close to 50% has reignited public concern about its potential for resulting in a pandemic like that of the 2002-to-2003 outbreak of severe acute respiratory syndrome (SARS) that emerged first in Asia, eventually killing 774 of ϳ8,000 infected individuals worldwide (3) . Built on the platform established over the last decade in dealing with the SARS epidemic, tremendous progress toward unraveling the genome, cellular tropism, and susceptibility to biological intervention has been achieved at an unprecedented speed. Based on genomic and phylogenetic analyses, MERS-CoV belongs to the lineage c beta (␤)-CoVs and is more closely related to Asian bat CoVs than to other ␤-CoVs, including SARS-CoV (lineage b), OC43, and HKU1 (human viruses in lineage a) (4) . While SARS-CoV utilizes human angiotensin-converting enzyme 2 (hACE2) as the functional receptor (5) (6) (7) , MERS-CoV exploits an evolutionarily conserved CD26/dipeptidyl peptidase 4 (DPP4) molecule to enter permissive cells of different mammalian species (8) . While MERS-CoV, like SARS-CoV, readily infects differentiated primary human airway epithelial cells (HAEC) and releases infectious progeny virus predominantly through the apical surface, it seems to be more vulnerable than SARS-CoV to prior alpha interferon (IFN-␣) treatment (9) . While these findings have significant implications for the development of effective strategies against this newly emerged human respiratory viral disease, a better understanding of how this virus interacts with host cells will be crucial for advancing the current knowledge of MERS-CoV pathogenesis. In particular, unveiling the distribution of the entry CD26/DPP4 receptor, on the membrane of HAEC, the main portal of entry of respiratory pathogens, and the subsequent outcome of MERS-CoV infection still await full investigation.
We previously showed that polarized human bronchial epithelial Calu-3 cells are susceptible to ACE2-mediated SARS-CoV infection exclusively through the apical surface accompanied by the release of infectious progeny virus predominantly via the apical surface (10) . In this study, we first compared the infectivity char-acteristics of SARS-CoV and MERS-CoV in Calu-3 cells and three other SARS-CoV-permissive human cell lines, i.e., the naturally ACE-2-expressing colonic epithelial LoVo cells and alveolar epithelial A549 and embryonic kidney 293 cells, both of which stably express ACE-2 following transfection (5, 11) . SARS-CoV (Urbani) and MERS-CoV (EMC-2012) were used throughout this study. As shown in Fig. 1A , MERS-CoV replicated to titers of 10 5 to 10 6 at 24 h postinfection (pi) in both Calu-3 and LoVo cells but not in ACE-2-expressing A549 or 293 cells, confirming the ACE-2-independent nature of MERS-CoV infection (12) . We also noted that the 24-h infection was in striking contrast to the delayed development of a microscopically visible cytopathic effect (CPE), which usually does not occur until day 5 pi, at the earliest, in SARS-CoV-infected Calu-3 cells (10), and that MERS-CoV infection resulted in extensive detachment of the monolayer within 24 h, an observation consistent with recent reports (13, 14) . Further, the formation of such an acute and profound CPE seemed to be specific to infected Calu-3 cells, as it took at least 4 days for infected LoVo cells to show ϳ10% to 15% CPE (data not shown). We also established the "one-step" growth curves of MERS-CoV versus SARS-CoV in Calu-3 cells by using a multiplicity of infection (MOI) of 3. Despite the fact that MERS-CoV failed to replicate as dynamically as SARS-CoV at both 8 and 32 h pi (P Ͻ 0.01) ( Fig. 1B) , it consistently induced readily detectable CPE at 16 h with ϳ20% monolayer detachment, which rapidly progressed to 70% and 100% at 24 and 32 h pi, respectively (data not shown). As anticipated, we did not observe any CPE in SARS-CoV-infected cultures at day 4 when the experiment was terminated. Since it has been demonstrated that CD26/DPP4 expression on cells of nonlymphoid origin, such as African green monkey COS-7 fibroblasts, confers their susceptibility to MERS-CoV infection (8), we asked whether expression of CD26/DPP4 on lymphoid cells could also enable their susceptibility to the infection. Thus, we infected human Jurkat T cells stably transfected with either a human CD26/DPP4-encoded plasmid (Jurkat_CD26DPP4ϩ) or a control plasmid (pcDNA) (Jurkat_C) (15) with MERS-CoV (MOI ϭ 1) and monitored the yields of infectious progeny viruses. As shown in Fig. 1C to E, expression of CD26/DPP4 on Jurkat T cells also readily converted their nonsusceptible state to a susceptible state and then to productive MERS-CoV infection, resulting in ϳ80% and ϳ88% cell death within 1 day and 2 days 2 pi, respectively, based on a trypan blue exclusion assay. CD26/DPP4 glycoprotein has been shown to express on many cell types, thereby regulating numerous biological functions, including, but not limited to, activation of T cells and their interaction with antigenpresenting cells (APCs) (16, 17) . Provided that subsets of T cells and/or dendritic cells expressing CD26/DPP4 were also as susceptible to MERS-CoV infection, one might anticipate the devastating impact that such an infection could have on the host innate and adaptive immune responses to this newly emerged human respiratory disease.
MERS-CoV has been shown to be more vulnerable than SARS-CoV to prior treatments with IFN-␣/ and IFN-␤ in primary HAEC and Calu-3 cells, respectively, resulting in either reduced or completely inhibited viral replication (9, 13) , suggesting the existence of some variations in the effectiveness of prior IFN treatment of infections by this virus. We compared the relative impact of prior treatment with a high dose of IFN-␤ (Peprotech) (1,000 U) on the replication of SARS-CoV versus MERS-CoV in Calu-3 cells. We found not only that prior IFN-␤ treatment for 16 h can significantly reduce the infections of the two viruses (MOI ϭ 0.1) equally well (P Ͻ 0.001) but also that it can noticeably attenuate the burden of CPE caused by MERS-CoV (Fig. 2) , an observation consistent with a recent report (14) . Similar to infection with an MOI of 3, MERS-CoV replicates significantly less than does SARS-CoV in Calu-3 cells (P Ͻ 0.05) when infected at an MOI of 0.1. Taken together, our data fail to fully support the earlier notions that MERS-CoV replicates more efficiently in permissive human airway epithelial cells and is more sensitive to IFN-mediated antiviral responses than SARS-CoV (8, 17) .
The profound CPE elicited by MERS-CoV-infected Calu-3 cells prompted us to investigate if apoptosis plays any role in this process. We initially analyzed, by confocal microscopy (Olympus FV 1000), Calu-3 cells grown in chamber slides (Nunc Lab-Tek II) infected for 24 h with either SARS-CoV or MERS-CoV (MOI ϭ 0.1), or those remaining uninfected, for the characteristic markers of apoptosis, e.g., unique nuclear morphology and expression of cleaved caspase-3 (CCP3). In contrast to the homogeneously round and smooth nuclei (4=,6-diamidino-2-phenylindole [DAPI] stained) we detected in mock-or SARS-CoV-infected cells (Fig. 3A and B) , in MERS-CoV-infected cells, we readily found prominent nuclear margination (arrows, Fig. 3C ), chromatin condensation (arrows, Fig. 3C ), and typical apoptotic bodies (arrowheads, Fig. 3C ) accompanied by CCP3-positive (CCP3 ϩ ) staining with fluorescein isothiocyanate (FITC)-conjugated anti-CCP3 antibody (Cell Signaling). The latter findings led us to conclude that caspase-dependent apoptosis is likely a prominent mechanism of the aforementioned cell death process. Dual staining with fluorescent annexin V and propidium iodide (PI) in conjunction with flow cytometry-based analyses has been widely used to simultaneously discriminate between and quantify caspase-dependent apoptotic and caspase-independent necrotic cells. Thus, annexin V ϩ /PI Ϫ staining is regarded as representative of earlystage apoptosis whereas annexin V ϩ /PI ϩ and annexin V Ϫ /PI ϩ staining is regarded as representative of late-stage apoptosis or necrosis. Unfortunately, the extreme difficulty in fully dissociating the tightly adherent Calu-3 monolayer into a single-cell suspension, along with the inability to retain PI staining in paraformaldehyde-fixed cells to inactivate residual viruses, a required step for gaining access to our flow cytometry, prohibits us from doing so. Thus, dually FITC-conjugated annexin V-and PI (catalog no. 556570; BD Pharmingen)-stained Calu-3 cells which were infected with MERS-CoV for 12 and 24 h, at MOIs of 0.1 and 3, along with uninfected controls, were subjected to examination by using an inverted phase-contrast fluorescence microscope (Olympus 1X71). In contrast to the essentially negative staining of uninfected (i.e., annexin V Ϫ /PI Ϫ ) cells, MERS-CoV-infected cells readily expressed an array of quantitatively different phenotypes, including the most abundant annexin V ϩ /PI Ϫ staining, followed by annexin V ϩ /PI ϩ staining, and, occasionally, annexin V Ϫ /PI ϩ staining, in an infectious dose-and time-dependent manner (Fig.  3D ). While dually stained cells were also detected, annexin V ϩ / PI Ϫ cells emerged as the dominant cell type associated with foci of CPE (Bright field, arrows), emphasizing the critical involvement of apoptosis in MERS-CoV-induced epithelial damage. This notion is best exemplified by cells infected with an MOI of 3, in which the great majority of positively stained cells were either annexin V ϩ /PI Ϫ (ϳ80%) or annexin V ϩ /PI ϩ (ϳ15%), with very few (if any) annexin V Ϫ /PI ϩ at 12 h pi when the infected monolayer remained completely undetached, whereas annexin V Ϫ or weak /PI ϩ became the major death phenotype of less than 5% of the monolayer remaining attached at 24 h pi. We also noted that a few clusters of cells retained an annexin V Ϫ /PI Ϫ phenotype (Bright field, arrowheads), which may mean that they survived following the infection for at least 24 h.
The predominant ACE2 expression on the apical surface of Calu-3 cells enables the entry and release of SARS-CoV unilaterally through the apical side (10) . We asked whether the entry receptor of MERS-CoV, CD26/DPP4, like ACE2, was also preferentially expressed on the apical domain of Calu-3 cells. To this end, we fixed Calu-3 cells grown onto chamber slides with 4% paraformaldehyde, stained with a primary antibody specifically against human CD26/DPP4 (AF1180; R&D) in combination with an FITC-conjugated secondary antibody (catalog no. A11055; Invitrogen) and assessed their membrane expression of CD26/DPP4 by z-scanning from the bottom, the middle, and the top by using inverted confocal microscopy (Zeiss LSM 710). In contrast to ACE2, which exclusively expresses on the apical domain of Calu-3 cells (10), we noted that CD26/DPP4 indiscriminately expressed on the entire membrane of Calu-3 cells, as revealed by sequential images caught by z-scanning ( Fig. 4A) , implying that MERS-CoV might be able to infect polarized Calu-3 cells through either the apical or basolateral domains. To test this, we established highly polarized Calu-3 cells in the transwell system (Costar). Briefly, confluent Calu-3 monolayers were allowed to fully differentiate in the presence of an air-liquid interface for an additional 4 days before being subjected to infection with SARS-CoV versus MERS-CoV (MOI ϭ 0.1) via either side of the culture (10) . The superna- 0.1) . The resulting cell-free supernatants were harvested at 24 h postinfection (pi) to determine the titers of infectious viruses as described for Fig. 1 (A) , whereas the infected monolayer was fixed with paraformaldehyde (4%)-phosphate-buffered saline (PBS) for documentation of MERS-CoV-induced CPE (B). *, P Ͻ 0.05; ***, P Ͻ 0.001 (Student's t test). tants harvested at 24 h pi from either chamber were used to determine the yields of progeny viruses. Consistent with our earlier report (10), SARS-CoV infected and released almost exclusively through the apical side of differentiated Calu-3 (Fig. 4B ). In contrast, MERS-CoV was indeed capable of doing so through either side of polarized Calu-3 cells (Fig. 4C ). While MERS-CoV could be released through both routes, we noted that there was an ϳ100fold-higher titer released basolaterally when infection was carried out from the basolateral rather than the apical routes.
Taken together, our results emphasize the fundamental differences in the spread and pathogenesis of these two highly pathogenic human CoVs. Additionally, the ability of MERS-CoV to infect through the basolateral domain of highly differentiated human bronchial epithelial cells is compatible with a blood-borne dissemination of virus, suggesting to us that an additional route other than the respiratory track should be considered for this viral infection.
